Diabetic Coma

Diabetic coma or diabetic ketoacidosis – (DKA) occurs when a diabetic does not properly balance their insulin intake with their diet or activity.

What is a Diabetic Coma?

Diabetic coma is a rare but serious occurrence. It is important to be aware of the risks of coma in diabetic patients and the possible causes.

Diabetic Coma Severe Hypoglycemia

Advanced Diabetic Ketoacidosis

Latest Diabetic Coma News and Research

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

In one of the largest and most racially diverse studies to date of American children and adolescents with type 1 and type 2 diabetes, researchers at Johns Hopkins Medicine, Baylor College of Medicine and the University of Wisconsin have identified the clinical and demographic factors associated with pediatric diabetic retinopathy.

7 Oct 2021

Study could offer a new way to treat Type 1 and Type 2 diabetes

Blocking cell receptors for glucagon, the counter-hormone to insulin, cured mouse models of diabetes by converting glucagon-producing cells into insulin producers instead, a team led by UT Southwestern reports in a new study.

1 Mar 2021

Tattoo sensor: A needleless glucose monitor for diabetes patients

For Angela Valdez, being diagnosed with diabetes was an awakening. The disorder ran in her family, but she didn't think it would happen to her. And when it did, she acted by modifying her diet and physical activity. She was doing everything right--almost.

20 Apr 2018

Treatment outcomes in type 1 diabetes could be improved across all age groups

In a sweeping analysis assessing the current state of diabetes treatment in the U.S., T1D Exchange researchers conclude that there remains considerable room for improving treatment outcomes in type 1 diabetes across all age groups, but especially for adolescents and young adults.

22 May 2015

New data supports use DAAs in patients with HCV recurrence following liver transplantation

New data presented today at The International Liver Congress 2015, supports the use of sofosbuvir (SOF)- and daclatasvir (DCV)-based regimens in patients with recurrence of the hepatitis C virus (HCV) following liver transplantation (LT).

25 Apr 2015

Study explains why generic insulin remains out of reach for diabetes patients

A generic version of insulin, the lifesaving diabetes drug used by 6 million people in the United States, has never been available in this country because drug companies have made incremental improvements that kept insulin under patent from 1923 to 2014.

23 Mar 2015

State highlights: Battle over jail medical care in Texas jails; Medicaid coverage for inmates; N.C. docs sue over Medicaid billing system

In November, David Conis Jr. sat in a Henderson County courtroom, vomiting repeatedly because of his vacillating blood-sugar levels, terrified that he was facing a diabetic coma. ... Henderson County state district Judge Carter Tarrance, concerned that the county jail was not providing adequate care, sent Conis to a local clinic and ordered the jail to follow the doctor's instructions (Grissom, 1/17).

20 Jan 2014

WHO welcomes forthcoming agreement to improve health care access

WHO welcomes the forthcoming agreement at a High-Level Meeting at the United Nations General Assembly which will further improve access to health care and related services for people with disabilities and ensure that they are able to contribute to the sustainable development of their communities.

21 Sep 2013

Researchers develop smartwatches to uncover reasons behind sleeping problems

Tonight will be another sleepless night for countless people, who will toss and turn for hours. And when they finally drift off, they will wake up with a start a short while later. If their disorder becomes chronic, sufferers often take part in medical sleep studies in an attempt to uncover the reasons behind their sleeping problems.

14 Aug 2013

Researchers develop new method for continuous glucose monitoring in patients with type 1 diabetes

Researchers at the Universitat Politècnica de València and the Universitat de Girona have developed a new method for continuous glucose monitoring in patients with type 1 diabetes.

8 May 2013

Longer looks: 'Bad suga' damages a neighborhood; A nurse's dying gift; Are ethical guidelines impeding patient care?

Bad suga' is devastating my neighborhood of North Lawndale, one of Chicago's poorest communities. Diabetes is commonly called "bad suga'" in many African American communities like the one where I grew up and live today.

18 Jan 2013

Elimination of glucagon action may help convert Type 1 diabetes into non-insulin-dependent disorder

Type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone, new findings by UT Southwestern Medical Center researchers suggest.

27 Jan 2011

UT Southwestern initiates study on hormone leptin for people with type 1 diabetes

A clinical trial at UT Southwestern Medical Center aims to determine whether adding the hormone leptin to standard insulin therapy might help rein in the tumultuous blood-sugar levels of people with type 1 (insulin-dependent) diabetes.

11 Oct 2010

First US forum gathers doctors and children who no longer need insulin

Twenty-five families who have overcome diabetes caused by a defect in a single gene will gather at "Celebrating the Miracles," a University of Chicago symposium for patients, parents and physicians. The first Monogenic Diabetes Forum is designed to review scientific studies, celebrate treatment successes, stress the importance of a genetic diagnosis for children diagnosed before age one, and exchange tips on how to make the most of a new concept--life without insulin injections.

3 Jul 2010

New study shows leptin treatment may help reduce type 1 diabetes

Using leptin alone in place of standard insulin therapy shows promise in abating symptoms of type 1 diabetes, UT Southwestern Medical Center researchers report.

24 Mar 2010

Genetic factors play an important role in the development of type 1 diabetes

Under the direction of Prof. Dr. Anette Ziegler, scientists of the Diabetes Research Group at Helmholtz Zentrum München and Technische Universität München investigated the formation of antibodies to a zinc transporter in children with elevated risk for type 1 diabetes. The study provided indications of an early onset of the disease when specific antibodies in the blood and specific variants of the associated zinc transporter are present in the genome.

30 Sep 2009